Sign in
4

Changes in Ownership

Veradermics, Inc Filed Acc 0001628280-26-005897

Chief Executive Officer acquired 1,437 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Waldman Reid Alexander Chief Executive Officer 2026-02-05 Conversion +1,437 234,872 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Waldman Reid Alexander Chief Executive Officer 2026-02-05 Conversion · Series A Convertible Preferred Stock −1,437 0 D: show line 2 in the form
Waldman Reid Alexander Chief Executive Officer 2026-02-03 Grant or award · Stock Option (Right to Buy) +556,399 556,399 D: show line 3 in the form
Loading xslF345X05/wk-form4_1770336007.xml…